Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001144204-18-002522

Chief Financial Officer sold 12,400 shares at $7.75 ($96,100)

  • Chief Financial Officer acquired 12,400 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
BLOCH KATHLEEN P. Chief Financial Officer 2018-01-12 Option exercise +12,400 $4.69 $58,156 241,038 D: show line 1 in the form
BLOCH KATHLEEN P. Chief Financial Officer 2018-01-12 Sale −12,400 $7.75 $96,100 228,638 D: show line 2 in the form
Open-market sales · 12,400 sh · avg $7.75 · $96,100

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
BLOCH KATHLEEN P. Chief Financial Officer 2018-01-12 Option exercise · Stock Option (Right to Buy) −12,400 37,200 D: show line 3 in the form
Loading xslF345X03/tv483528_4.xml…